Restrictive Delhi HC order pushes India's online pharmacies on the backfoot
Investors have continued to pour in significant amounts of capital in the burgeoning space, but the latest court decision is likely to affect future investments. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 14, 2018 Category: Pharmaceuticals Source Type: news

EU court upholds EUR 13.96 mn fine on Unichem Lab in Perindopril litigation
In 2014, six global drug makers were fined EUR 427.7 million for striking deals to prevent entry of cheaper version of blood pressure drug Perindopril in the EU. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 13, 2018 Category: Pharmaceuticals Source Type: news

Dr Reddy's launches heartburn drug in US market
Dr Reddy's Laboratories said the combined market of Prilosec OTC and private label omeprazole OTC products had US retail sales of around $492 mn for the most recent 12 months ending in October 2018. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 11, 2018 Category: Pharmaceuticals Source Type: news

Cadila Healthcare arm gets USFDA nod for ulcer treatment injection
The company has more than 237 approvals, and has so far filed over 340 abbreviated new drug applications (ANDAs) since it commenced filings in 2003-04. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 11, 2018 Category: Pharmaceuticals Source Type: news

Aurobindo Pharma arm enters pact to form JV in China with Luoxin
"The percentage of shareholding in the joint venture company will be 30 per cent and 70 per cent between Helix and Luoxin," Aurobindo Pharma said. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 11, 2018 Category: Pharmaceuticals Source Type: news

Sun Pharma promoters take a hit on personal investments
Some of their biggest personal investments have been in power and real estate, and both sectors and their holdings have taken a beating, according to publicly available data. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 11, 2018 Category: Pharmaceuticals Source Type: news

Alembic Pharmaceuticals gets USFDA nod for ophthalmic solution
The company has received approval from the USFDA for its abbreviated new drug application (ANDA) Olopatadine Hydrochloride ophthalmic solution USP, 0.1 per cent, Alembic Pharmaceuticals said in a filing to BSE. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 10, 2018 Category: Pharmaceuticals Source Type: news

Lupin gets EIR from USFDA for Pithampur facility unit
Lupin's Pithampur facility manufactures dermatological products, dry product inhalers, and metered dose inhalers. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 10, 2018 Category: Pharmaceuticals Source Type: news

USFDA recommends regulatory action after Jubilant Life's Roorkee plant inspection
According to the FDA, Official Action Indicated means regulatory and/or administrative actions will be recommended against a facility after an inspection. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 8, 2018 Category: Pharmaceuticals Source Type: news

Malvinder and Shivinder Singh trade assault charges
While Shivinder in a statement has denied these claims and instead alleged that it was Malvinder who assaulted him, his elder brother has alleged that Shivinder disrupted the meeting of the company, which owes them dues. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 8, 2018 Category: Pharmaceuticals Source Type: news

USFDA makes 22 observations post inspection of Lupin's Mandideep facilities
Lupin said the observations are "largely procedural in nature with some gaps identified in the aseptic processing areas of the Cephalosporin API block ” and the company is confident of addressing them satisfactorily. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 5, 2018 Category: Pharmaceuticals Source Type: news

Novartis India MD Milan Paleja to step down
Milan Paleja has informed the company's board of his decision to resign as the vice chairman and managing director effective May 31, 2019. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 5, 2018 Category: Pharmaceuticals Source Type: news

Investors irked by lack of disclosures at Sun Pharma
The lack of disclosures around non-related party transactions to the tune of Rs 2,200 crore has become a sore spot for investors, who are questioning the nature — and beneficiaries — of these loans. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 5, 2018 Category: Pharmaceuticals Source Type: news

Sun Pharma open to evaluating past decisions: Dilip Shanghvi
A WhatsApp forward leaked details of a report containing allegations of corporate governance improprieties (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 4, 2018 Category: Pharmaceuticals Source Type: news

Report on faulty hip replacement implants ready: Centre to SC
The apex court on October 5 had asked the Centre to file its response to the PIL alleging that "faulty" and "deadly" hip implants have been fitted into the bodies of 4,525 Indian patients. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 3, 2018 Category: Pharmaceuticals Source Type: news

Sun Pharma says open to evaluating certain business transactions if investors not comfortable with them
As of now the company has not received any query from Sebi with regard to whistleblower complaint, Sun Pharma Founder and MD Dilip Shanghvi said. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 3, 2018 Category: Pharmaceuticals Source Type: news

Whistle-blower complains to SEBI against Sun Pharma, alleges insider trading: Report
150-page document sent to market regulator in September, drugmaker says it has not yet been contacted by SEBI. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 1, 2018 Category: Pharmaceuticals Source Type: news

Kiran Mazumdar Shaw bats for easing regulations on biotechnology sector
"The erstwhile UPA regime and the present Modi government have taken some good steps, but have not done enough to improve the economy," Shaw said. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 29, 2018 Category: Pharmaceuticals Source Type: news

Patients with faulty Johnson & Johnson hip implants to be compensated up to Rs 1.23 crore
According to a statement issued by the ministry, patients who had received faulty hip implants prior to August, 2010 will be eligible for the compensation. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 29, 2018 Category: Pharmaceuticals Source Type: news

Jubilant Life arm inks pact to acquire Inipharm Inc for around USD 28.5 mn
Drug firm Jubilant Life Sciences' subsidiary Drug Discovery and Development Solutions Ltd (DDDSL) Singapore has entered into an agreement to acquire 10 per cent stake in Inipharm Inc USA (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 29, 2018 Category: Pharmaceuticals Source Type: news

Lupin CFO quits, to pursue opportunities outside pharma
Swaminathan as the CFO of Lupin, was part of some of company's biggest mergers and acquisition in US and Japan (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 27, 2018 Category: Pharmaceuticals Source Type: news

Alembic Pharma gets USFDA nod for insomnia treatment drug
The company has got approval from the US Food and Drug Administration (USFDA) to market the drug. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 27, 2018 Category: Pharmaceuticals Source Type: news

Alembic Pharma gets USFDA nod for Alembic Pharma
The approved product is therapeutically equivalent to AstraZeneca Pharmaceuticals' Xylocaine ointment, 5 per cent. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 26, 2018 Category: Pharmaceuticals Source Type: news

Lupin gets USFDA nod for antidepressant drug
The capsules are indicated for the treatment of obsessions and compulsions in patients with Obsessive-Compulsive Disorder (OCD), Lupin said. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 26, 2018 Category: Pharmaceuticals Source Type: news

Glenmark Pharma gets tentative USFDA nod for skin treatment drug
The approved product is a generic version of Mylan Pharmaceuticals Inc's drug (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 26, 2018 Category: Pharmaceuticals Source Type: news

Lupin launches first chatbot for patients to know about their ailments
As a start to digitize the patient journey in the overall healthcare space, Lupin is starting with ANYA to address queries related to diabetes. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 23, 2018 Category: Pharmaceuticals Source Type: news

77 percent Indian households use Ayurvedic products: PwC report
The size of the global Ayurvedic market is expected to almost treble from $3.4 billion in 2015 to $9.7 billion by 2022. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 23, 2018 Category: Pharmaceuticals Source Type: news

High Court quashes Abbott ’s plea to stall CCI probe into alleged cartelisation
Justice Vibhu Bakhru dismissed the petition on the grounds that there was no merit in the plea. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 20, 2018 Category: Pharmaceuticals Source Type: news

Indian ayurvedic industry to grow to $ 4.4 billion by the end of this year
To add to the bullish outlook, the Indian ayurveda industry is projected to record a compounded annual growth rate of a robust 16 % until 2025. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 19, 2018 Category: Pharmaceuticals Source Type: news

E-pharmacies divided over their legal status
Madras High Court will hear a petition from Tamil Nadu Chemists and Druggists Association that has challenged the existence of e-pharmacies. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 19, 2018 Category: Pharmaceuticals Source Type: news

ICMR to conduct trials of indigenously developed Zika vaccine
ICMR will undertake phase-II trial of the vaccine to establish the efficacy and safety of the vaccine along with its adverse effects. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 18, 2018 Category: Pharmaceuticals Source Type: news

Aurobindo Pharma to launch oncology, respiratory products in US by 2021
The company is also focussing on securing intellectual property (IP) and ramping up and filing of specialty products. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 18, 2018 Category: Pharmaceuticals Source Type: news

Glenmark gets USFDA nod for multiple sclerosis medication
The approved product is generic version of Sanofi-Aventis US' Aubagio. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 16, 2018 Category: Pharmaceuticals Source Type: news

Shilpa Medicare gets tentative USFDA nod for multiple sclerosis drug
The company's abbreviated new drug application (ANDA) for Dimethyl Fumarate delayed release capsules in the strengths of 120 mg and 240 mg has been granted tentative approval by the USFDA. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 16, 2018 Category: Pharmaceuticals Source Type: news

Zydus Cadila gets USFDA nod to market generic HIV treatment tablets
The approval from the USFDA is for Abacavir and Lamivudine tablets USP in the strength of 600 mg/300 mg, Zydus Cadila said. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 16, 2018 Category: Pharmaceuticals Source Type: news

It ’s official, Indian-made stents as good as the best
A study presented two months back had also concluded that another Indian stent, Supra Flex was as good as Xience. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 15, 2018 Category: Pharmaceuticals Source Type: news

Post GST, pharma sector grew 6 percent till May-end: Mansukh Mandaviya
Impact of the Goods and Services Tax (GST) on the sector has largely been positive and constructive, he added. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 15, 2018 Category: Pharmaceuticals Source Type: news

Apollo Hospitals to hive off retail pharmacy business into new company
Apollo Pharmacy (APL) will be a wholly owned subsidiary of Apollo Medicals. The listed parent company, Apollo Hospitals Enterprise will hold 25.5% stake in Apollo Medicals (AMPL) . (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 14, 2018 Category: Pharmaceuticals Source Type: news

Cipla's subsidiary to acquire US-based Avenue Therapeutics for $ 215 million
At the second stage, InvaGen or its affiliates will acquire the remaining shares of Avenue's common stock, for up to USD 180 million in the aggregate. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 13, 2018 Category: Pharmaceuticals Source Type: news

Suven Life gets product patents from Australia, Hong Kong
These patents are valid till 2036 and 2033 respectively, the company said in a BSE filing. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 13, 2018 Category: Pharmaceuticals Source Type: news

Lupin gets USFDA nod for Asthma drug
Quoting IQVIA MAT September data, Lupin said, the said Asthma drug had annual sales of around USD 474.5 million in the US. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 13, 2018 Category: Pharmaceuticals Source Type: news

Aurobindo Pharma inks pact to acquire Australian pharma firm's product
Based out of Melbourne, Advent Pharmaceuticals is engaged in developing and commercialising generic inhaled medicines for global markets. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 13, 2018 Category: Pharmaceuticals Source Type: news

Aurobindo Pharma to acquire under development product, related assets from Advent for $12.5mn
The acquisition is for a cash consideration of USD 12.5 million, it added. The indicative time period for completion of the acquisition is January 2019, Aurobindo Pharma said. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 12, 2018 Category: Pharmaceuticals Source Type: news

Cipla gets USFDA nod for anti-viral eye infection drug for AIDS patients
The approved products is a generic therapeutic equivalent version of Roche's Valcyte. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 12, 2018 Category: Pharmaceuticals Source Type: news

Zydus Cadila gets USFDA nod for anti-fungal ointment
The group has more than 226 approvals, and so far filed over 330 abbreviated new drug applications (ANDAs) since it started filings in 2003-04. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 12, 2018 Category: Pharmaceuticals Source Type: news

We ’re just aggregators, e-pharmacies tell Madras High Court
This comes after the Madras High Court, in a recent injunction, restrained unlicenced e-pharmacies from doing business. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 5, 2018 Category: Pharmaceuticals Source Type: news

Clinical trials on Ayurvedic medicine against dengue underway: Shripad Naik
Rajesh Kotecha, secretary of AYUSH ministry, said the medicine is expected to be ready after multilevel trials in the next couple of years. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 4, 2018 Category: Pharmaceuticals Source Type: news

Aurobindo recalls hypertensive drug in US citing cancer risk
ScieGen Pharmaceuticals has initiated recall of the finished Irbesartan drug from the market, a separate notification by the FDA said. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 4, 2018 Category: Pharmaceuticals Source Type: news

Lupin recalls 6,752 bottles of Testosterone topical solution from US
The product is indicated for replacement therapy in males for conditions associated with a deficiency or absence of endogenous testosterone. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 4, 2018 Category: Pharmaceuticals Source Type: news

Indian pharma companies maintaining good compliance standards: Frances Zipp, CEO, Lachman Consultants
One of the unique opportunities for the industry to come out on scientific and safe manner is to engage closely on the latest developments in the industry, feels Frances Zipp, CEO at Lachman Consultants. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 3, 2018 Category: Pharmaceuticals Source Type: news